NPY C-399T

NPY rs16147 — The Stress Resilience and Appetite Variant

Neuropeptide Y | NPY is a 36-amino-acid peptide and the most abundant
neuropeptide in the human brain. It acts through five receptor subtypes
(Y1-Y5) to regulate feeding, stress, anxiety, pain, and cardiovascular
function (NPY) is the brain's most abundant neuropeptide and one of
the most potent appetite-stimulating molecules known. But NPY does far
more than drive hunger — it serves as a critical brake on the stress
response, dampening anxiety, modulating pain perception, and influencing
cardiovascular tone. The rs16147 variant sits in the promoter region of
the NPY gene, directly affecting how much NPY your cells produce,
particularly under stress. This makes it a rare example of a single
variant with documented effects across stress resilience, body weight
regulation, migraine susceptibility, and blood pressure.

The Mechanism

The rs16147 T>C substitution occurs 399 base pairs upstream of the NPY
gene's transcription start site, in a region that regulates gene
expression. The T allele creates a stronger binding site for
transcription factors, leading to
higher NPY expression, particularly under stress | Zhang K et al.
Association of neuropeptide Y promoter polymorphism (rs16147) with
perceived stress and cardiac vagal outflow in humans. Sci Rep,
2016. The C allele reduces
transcription factor binding affinity | The C-variant decreases protein
binding compared to the T-allele in electrophoretic mobility shift
assays, suggesting weaker promoter activation, resulting in lower
NPY output when the system is challenged.

This is not a simple on-off switch. Postmortem brain analysis of
107 human anterior cingulate cortex samples | Zhou Z et al. Human NPY
promoter variation rs16147:T>C as a moderator of prefrontal NPY gene
expression and negative affect. Hum Mutat,
2010 showed that the
rs16147 genotype accounts for a meaningful portion of individual
variation in NPY mRNA levels in this region — a brain area central to
emotional regulation and decision-making. The variant's effects are
context-dependent: differences between genotypes become most pronounced
under conditions of chronic stress or early adversity.

The Evidence

Stress resilience and mental health. In a study of
1,123 healthy Han Chinese adults | Zhang K et al. Association of
neuropeptide Y promoter polymorphism (rs16147) with perceived stress and
cardiac vagal outflow in humans. Sci Rep,
2016, TT homozygotes showed
significantly enhanced
cardiac vagal outflow | Vagal tone reflects parasympathetic nervous
system activity. Higher vagal tone is associated with better stress
recovery, emotional regulation, and cardiovascular health under
chronic high stress compared to CC homozygotes — indicating greater
parasympathetic resilience. No genotype differences emerged in the
low-stress group, confirming the gene-by-environment pattern. Research
in US military veterans | Watkins LE et al. Association between
functional polymorphism in neuropeptide Y gene promoter rs16147 and
resilience to traumatic stress in US military veterans. J Clin
Psychiatry, 2017 found the
T allele protective against PTSD intrusion symptoms in combat-exposed
populations. The rs16147 variant also interacts with early childhood
adversity to predict anxiety and depressive symptoms in young adults,
with the C allele functioning as a vulnerability factor.

Appetite and body weight. NPY is one of the most potent
orexigenic | Appetite-stimulating. NPY acts through hypothalamic Y1
and Y5 receptors to increase food intake, with a preferential effect on
carbohydrate consumption peptides in the brain. A
meta-analysis of 9 studies | Yeung EH et al. Comprehensive evaluation
of the neuropeptide-Y gene variants in the risk of obesity. Obesity,
2015 found the T allele
significantly associated with obesity risk (OR 1.27, 95% CI 1.04-1.55),
including higher BMI, waist circumference, triglycerides, and body fat
percentage. A longitudinal study following 306 individuals from infancy
to age 19 | Hohmann S et al. Increasing association between a
neuropeptide Y promoter polymorphism and body mass index during the
course of development. Pediatr Obes,
2012 showed the
genotype-BMI association strengthens during development, with T-allele
carriers diverging progressively from CC homozygotes. The
POUNDS LOST trial of 723 subjects | Qi Q et al. Neuropeptide Y
genotype, central obesity, and abdominal fat distribution. Am J Clin
Nutr, 2015 demonstrated
that rs16147 genotype modifies the effect of dietary fat on abdominal
adiposity — T allele carriers gained more visceral fat on high-fat diets.

Migraine and pain. NPY dose-dependently
inhibits dural trigeminal neuron firing | Martins-Oliveira M et al.
Neuropeptide Y inhibits the trigeminovascular pathway through NPY Y1
receptor: implications for migraine. Pain,
2016 through the Y1
receptor, achieving up to 40% suppression of baseline activity. Lower
NPY expression (C allele) could theoretically reduce this endogenous
pain-braking mechanism. Changes in NPY levels have been documented in
migraine patients, and disruption of the NPY system may explain appetite
disturbances commonly reported during migraine attacks.

Blood pressure. The same POUNDS LOST trial | Zhang X et al.
Neuropeptide Y promoter polymorphism modifies effects of a weight-loss
diet on 2-year changes of blood pressure. Hypertension,
2012 found that rs16147
genotype modifies blood pressure response to dietary interventions, with
differential effects depending on dietary fat content — highlighting
NPY's role in sympathetic cardiovascular regulation.

Practical Implications

This variant presents an unusual trade-off. The T allele confers greater
stress resilience and enhanced parasympathetic tone under pressure — but
also predisposes to higher appetite drive and central fat accumulation,
especially on high-fat diets. The C allele is associated with lower
obesity risk but greater vulnerability to anxiety and stress-related
conditions when exposed to adversity.

The actionable implications depend on your genotype: C allele carriers
benefit from targeted stress-buffering strategies and may want to
monitor for anxiety symptoms during stressful periods. T allele carriers
should be aware of their heightened appetite drive, particularly for
carbohydrates, and may benefit from dietary fat moderation to manage
abdominal fat accumulation.

Interactions

NPY and BDNF (rs6265) converge on stress resilience pathways. Both
neuropeptides are released in an activity-dependent manner and both
modulate the HPA axis stress response. Individuals carrying both the
NPY rs16147 CC genotype (lower stress-induced NPY) and the BDNF Met
allele (rs6265 CT or TT, reduced activity-dependent BDNF release)
may experience compounded vulnerability to stress-related mood
disturbance, as both endogenous stress-buffering systems are
attenuated simultaneously.

NPY also interacts with the HPA axis through FKBP5 (rs1360780). FKBP5
regulates glucocorticoid receptor sensitivity, and impaired NPY
stress-braking combined with enhanced glucocorticoid signaling
(rs1360780 T allele) could amplify stress reactivity beyond what
either variant produces alone.